應用參考文獻

[1] Pollastro S, Klarenbeek P L, Doorenspleet M E, et al. Non-response to rituximab therapy in rheumatoid arthritis is associated with incomplete disruption of the B cell receptor repertoire[J]. Annals of the Rheumatic Diseases, 2019: annrheumdis-2018-214898.

[2] Mo W X, Yin S S, Chen H, et al. Chemotaxis of Vδ2 T cells to the joints contributes to the pathogenesis of rheumatoid arthritis[J]. Annals of the rheumatic diseases, 2017, 76(12): 2075-2084.

[3] Zhang F, Wei K, Slowikowski K, et al. Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry[J]. Nature immunology, 2019, 20(7): 928.

[4] Deng J, Wei Y, Fonseca V R, et al. T follicular helper cells and T follicular regulatory cells in rheumatic diseases[J]. Nature Reviews Rheumatology, 2019: 1.

[5] Martin P, Ding J, Duffus K, et al. Chromatin interactions reveal novel gene targets for drug repositioning in rheumatic diseases[J]. Annals of the rheumatic diseases, 2019, 78(8): 1127-1134.